RevMedx is pleased to announce the launch of the FDA cleared XSTAT® P30 – an improved version of our revolutionary hemostatic devices. XSTAT P30 was developed in collaboration with the US Military to expand the usability and functionality of the XSTAT 30 Generation 2 by improving the ease-of-use and reducing cube space.
In the XSTAT P30 device, the minisponges are enclosed in three porous pouches to facilitate their removal from wounds. Each minisponge pouch is large enough to be easily seen and removed in a manner identical to other standard-of-care dressings used to treat or pack bleeding wounds—essentially eliminating the risk that any minisponges could be inadvertently left in a wound following treatment. Results of a GLP Femoral Swine study demonstrate identical safety and effectiveness as original XSTAT.
Category: Uncategorized
XSTAT Profiled in JSOM Newsletter
The XSTAT hemorrhage control device is now featured in the November 1 2020 edition of the Journal of Special Operations Medicine Online Newsletter. This device profile discusses the origins, advantages and uses of this innovative mini sponge technology. Access the JSOM Newsletter here or download the .pdf below.
TX® Series added to CoTCCC list of recommended limb tourniquets
RevMedx, Inc., a leader in groundbreaking solutions for the control of severe bleeding, today announced that the CoTCCC has added the TX Series ratcheting tourniquets to its list of recommended Limb Tourniquets. The TX series joins the XSTAT® injectable hemostatic on the TCCC list of recommended hemorrhage control devices for casualty care.
Andrew Barofsky, President and CEO of RevMedx, Inc., stated, “We are pleased that yet another RevMedx product is now part of the TCCC guidelines. Our company is dedicated to adding innovative solutions for first responders and medics around the world.”
The United States Army Institute of Surgical Research reports that 30 to 40 percent of civilian deaths by traumatic injury are the result of hemorrhage, many of which occur before the patient reaches an emergency care facility. For victims of violence or accidents, early control of severe bleeding may prevent shock and save a life.
While there are a variety of tourniquets on the market, their narrow width and windlass tightening mechanism pose limitations to ease of use and patient comfort.
Some research suggests that wider tourniquets have been known to provide better patient comfort during application and transport as well as having the potential to minimize tissue and nerve damage during application. The TX2 and TX3 (2 and 3 inches wide respectively) are the widest non-pneumatic tourniquets recommended by TCCC. With an intuitive and simple ski boot ratchet design, the TX series enable fast application with minimal training.
About RevMedx
Based in Wilsonville, Oregon, RevMedx is a privately held medical device company whose goal is to design, develop, and manufacture innovative medical products that save lives. Our product line includes XSTAT, XGAUZE, AIRWRAP, PARABELT, SHARKBITE Blast Injury Kits, and TX Series Ratcheting Tourniquets. Additional information about RevMedx and our products can be found at www.revmedx.com.
